<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药融圈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-18T12:12:07+08:00</updated>
  <subtitle>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>心血管重磅新药VASCEPA®落地博鳌，专家解读心血管事件残余风险破解之法</title>
    <updated>2021-01-17T22:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/tbq-vwYvzpKQ74VQOIyVwQ</id>
    <link href="https://mp.weixin.qq.com/s/tbq-vwYvzpKQ74VQOIyVwQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百明信康完成近2亿元A轮融资，打造领先过敏诊疗平台</title>
    <updated>2021-01-17T22:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/zVpNfhtIKrRQgtN4r_vn8g</id>
    <link href="https://mp.weixin.qq.com/s/zVpNfhtIKrRQgtN4r_vn8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“长寿药”NMN迎来致命打击 ，国家局启动严查</title>
    <updated>2021-01-17T22:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/ADdJz7magQhR5Y7zUKvr7w</id>
    <link href="https://mp.weixin.qq.com/s/ADdJz7magQhR5Y7zUKvr7w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新锐|A轮融资6200万美元，加速taladegib治疗特发性肺纤维化临床</title>
    <updated>2021-01-17T22:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/N9geameuwosi7YJbLDYlrA</id>
    <link href="https://mp.weixin.qq.com/s/N9geameuwosi7YJbLDYlrA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>B轮超额融资6200万美元，仅有一款MEK抑制剂处于临床前</title>
    <updated>2021-01-17T22:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/-zZyt6-APiwpB2O0eTYenw</id>
    <link href="https://mp.weixin.qq.com/s/-zZyt6-APiwpB2O0eTYenw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶点药讯44|纵览全球药物靶点动态</title>
    <updated>2021-01-17T22:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/tnz28VhCV5-PXFL_m38Ptw</id>
    <link href="https://mp.weixin.qq.com/s/tnz28VhCV5-PXFL_m38Ptw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>结束20余年备胎生涯---诺华奥马珠单抗重磅接班人Ligelizumab现身台前</title>
    <updated>2021-01-17T22:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/3yw0BbPIxVzTfyYroJhzeQ</id>
    <link href="https://mp.weixin.qq.com/s/3yw0BbPIxVzTfyYroJhzeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>不内卷||细数那些转型CMO/CDMO成功的原料药企</title>
    <updated>2021-01-16T20:38:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/-cfps01tP3s_bJg0LZMafQ</id>
    <link href="https://mp.weixin.qq.com/s/-cfps01tP3s_bJg0LZMafQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！大数据智能医疗公司医渡云港股正式IPO，市值达574亿港元</title>
    <updated>2021-01-16T20:38:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/eMWOxa1QzGMHDh2w9qIf5Q</id>
    <link href="https://mp.weixin.qq.com/s/eMWOxa1QzGMHDh2w9qIf5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>1100万美元A轮融资，加快治疗淋巴水肿和静脉疾病产品商业化</title>
    <updated>2021-01-16T20:38:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/9y6JBmNCJQ-RB2PVd6PCpw</id>
    <link href="https://mp.weixin.qq.com/s/9y6JBmNCJQ-RB2PVd6PCpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>B轮融资1.55亿美元，加速IDO和PD-L1癌症疫苗临床试验</title>
    <updated>2021-01-16T20:38:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/k34_yXmXtpExcmH9RXGXbw</id>
    <link href="https://mp.weixin.qq.com/s/k34_yXmXtpExcmH9RXGXbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>纳入十四五规划，疫苗行业千亿市场规模近在咫尺</title>
    <updated>2021-01-16T20:38:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/5f98r36xjXrg4KW8c4Rcfw</id>
    <link href="https://mp.weixin.qq.com/s/5f98r36xjXrg4KW8c4Rcfw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>千亿市场需求-抗高血压药物市场简析</title>
    <updated>2021-01-16T20:38:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/rdirV97BEGD8kIg8v3Udhg</id>
    <link href="https://mp.weixin.qq.com/s/rdirV97BEGD8kIg8v3Udhg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚！第四批《全国药品集中采购文件（GY-YD2021-1）》发布！附各品种、各省区报量！</title>
    <updated>2021-01-16T20:38:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/GhOdBCoqOYjDBlZRi8rFAQ</id>
    <link href="https://mp.weixin.qq.com/s/GhOdBCoqOYjDBlZRi8rFAQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>科伦药业注射剂新品将获批 或将成为国内第二</title>
    <updated>2021-01-16T20:38:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/iq7GoXxZ8HSSmJ6EJPLU5w</id>
    <link href="https://mp.weixin.qq.com/s/iq7GoXxZ8HSSmJ6EJPLU5w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NMN在中国查无此“药”？—关于国内外膳食补充剂监管法规的差异化研究</title>
    <updated>2021-01-15T16:36:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/c-sO6eILkfRCyn_OTuO4QQ</id>
    <link href="https://mp.weixin.qq.com/s/c-sO6eILkfRCyn_OTuO4QQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年，值得医药人关注的公众号有哪些?</title>
    <updated>2021-01-15T16:36:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/4m_kaAEgT1En0BAc-M6J5w</id>
    <link href="https://mp.weixin.qq.com/s/4m_kaAEgT1En0BAc-M6J5w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>厉害了药明，将新药卖到中国人民解放军总医院</title>
    <updated>2021-01-15T16:36:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/qntUD9ok9v253yUpPaY_qg</id>
    <link href="https://mp.weixin.qq.com/s/qntUD9ok9v253yUpPaY_qg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>盟科上市辅导：抗感染新药第一股</title>
    <updated>2021-01-15T16:36:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/fMk48dLc1KwMMyjfBDPszw</id>
    <link href="https://mp.weixin.qq.com/s/fMk48dLc1KwMMyjfBDPszw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>特色医药供应商/CDMO：毕得医药辅导上市</title>
    <updated>2021-01-15T16:36:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/DY3VoJkVYkg47gXgvmHnSw</id>
    <link href="https://mp.weixin.qq.com/s/DY3VoJkVYkg47gXgvmHnSw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>